Yesterday, the CBO & EVP of Ultragenyx Pharmaceutical (RARE – Research Report), Thomas Richard Kassberg, sold shares of RARE for $23.05K. Following Thomas Richard Kassberg’s last RARE Sell transaction on February 03, 2014, the stock climbed by 53.0%. In addition